+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Intranasal Drug and Vaccine Delivery Market Size, Share & Trends Analysis Report by Product, Dosage, Application, Distribution Channel, Region, and Segment Forecasts, 2025-2030

  • PDF Icon

    Report

  • 100 Pages
  • October 2024
  • Region: Global
  • Grand View Research
  • ID: 6024620
Description Jump to:

The global intranasal drug and vaccine delivery market size is estimated to reach USD 103.33 billion by 2030, registering to grow at a CAGR of 6.6% from 2025 to 2030 . Increasing preference for nasal products over parenteral and oral formulations for instant relief is one of the major factors driving the market.



Increasing demand and advancements in technology are some of the major market drivers. Rising investment in research and development has escalated the clinical trial programs indicated for the treatment of various conditions. In March 2020, Auris Medical Holding Ltd. provided the Phase 2 trial update for intranasal betahistine (AM-125) for the treatment of acute peripheral vertigo.

Increasing prevalence of chronic respiratory disorders augments the demand for intranasal drug and vaccine devices as they are commonly prescribed by medical professionals owing to the easy self-administration technique. According to the Centers for Disease Control and Prevention (CDC), in 2019, 1 in 13 people have asthma, with more than 25 million Americans living with asthma. CDC also stated that asthma accounted for an estimated 14.2 million hospital visits, 439,000 hospital discharges, and 1.8 million emergency department visits annually.

Liquid delivery devices dominated the market in 2019 on account of their availability in various formulations, including aqueous solutions, emulsions, and suspensions. The unit-does segment is anticipated to witness lucrative growth due to increasing approvals for the treatment of various disorders. Moreover, majority of the vaccine formulations under development are unit-dose formulations as single intranasal vaccine dose is commonly recommended by medical professionals.

Asia Pacific is expected to emerge as the fastest growing regional market over the forecast period. This is primarily attributed to increasing product development protocols, economic growth, and increase in the number of local market players involved in the development of novel drug delivery systems.

Intranasal Drug And Vaccine Delivery Market Report Highlights

  • Liquid delivery devices dominated the market with a revenue share of 43.7% in 2024. These devices, including metered spray pumps, circumvent first-pass metabolism, enhancing bioavailability and accelerating therapeutic effects.
  • Multi-dose systems led the market with a revenue share of 64.1% in 2024. Multi-dose systems provide improved tolerance and convenience, enabling patients to self-administer medications with fewer refills.
  • Respiratory disorders held the largest market share of 41.1% in 2024, owing to the efficacy of intranasal delivery for conditions such as asthma, COPD, and allergic rhinitis.
  • Retail pharmacies dominated the market and accounted for a share of 45.1% in 2024, fueled by rising patient awareness and a growing trend towards self-administration of medications.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments
  • Competitive Landscape: Explore the market presence of key players worldwide
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

The leading players in the Intranasal Drug and Vaccine Delivery market include:

  • GSK plc
  • Teva Pharmaceutical Industries Ltd
  • AptarGroup, Inc.
  • UCB S.A., Belgium
  • Teleflex Incorporated
  • 3M
  • Bespak Limited
  • Optinose
  • Intersect ENT


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Dosage
1.2.3. Application
1.2.4. Distribution Channel
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Intranasal Drug and Vaccine Delivery Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
Chapter 4. Intranasal Drug and Vaccine Delivery Market: Product Business Analysis
4.1. Product Market Share, 2024 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Powder Delivery Device
4.4.1. Powder Delivery Device Market, 2018 - 2030 (USD Million)
4.5. Liquid Delivery Device (Metered Spray Pumps)
4.5.1. Liquid Delivery Device (Metered Spray Pumps) Market, 2018 - 2030 (USD Million)
4.6. Pressurized Metered Dose Inhaler
4.6.1. Pressurized Metered Dose Inhaler Market, 2018 - 2030 (USD Million)
4.7. Others
4.7.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Intranasal Drug and Vaccine Delivery Market: Dosage Business Analysis
5.1. Dosage Market Share, 2024 & 2030
5.2. Dosage Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Dosage, 2018 to 2030 (USD Million)
5.4. Unit-dose
5.4.1. Unit-dose Market, 2018 - 2030 (USD Million)
5.5. Multi-dose
5.5.1. Multi-dose Market, 2018 - 2030 (USD Million)
Chapter 6. Intranasal Drug and Vaccine Delivery Market: Application Business Analysis
6.1. Application Market Share, 2024 & 2030
6.2. Application Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Respiratory Disorders
6.4.1. Respiratory Disorders Market, 2018 - 2030 (USD Million)
6.5. Neurological Disorders
6.5.1. Neurological Disorders Market, 2018 - 2030 (USD Million)
6.6. Vaccination
6.6.1. Vaccination Market, 2018 - 2030 (USD Million)
6.7. Pain Management
6.7.1. Pain Management Market, 2018 - 2030 (USD Million)
6.8. Others
6.8.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Intranasal Drug and Vaccine Delivery Market: Distribution Channel Business Analysis
7.1. Distribution Channel Market Share, 2024 & 2030
7.2. Distribution Channel Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
7.4. Hospital Pharmacies
7.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
7.5. Retail Pharmacies
7.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
7.6. Online Pharmacies
7.6.1. Online Pharmacies Market, 2018 - 2030 (USD Million)
Chapter 8. Intranasal Drug and Vaccine Delivery Market: Regional Estimates & Trend Analysis by Product, Dosage, Application, and Distribution Channel
8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.4. North America
8.4.1. North America Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
8.4.2. U.S.
8.4.2.1. Key Country Dynamics
8.4.2.2. Regulatory Framework
8.4.2.3. Competitive Insights
8.4.2.4. U.S. Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.3. Canada
8.4.3.1. Key Country Dynamics
8.4.3.2. Regulatory Framework
8.4.3.3. Competitive Insights
8.4.3.4. Canada Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.4. Mexico
8.4.4.1. Key Country Dynamics
8.4.4.2. Regulatory Framework
8.4.4.3. Competitive Insights
8.4.4.4. Mexico Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5. Europe
8.5.1. Europe Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
8.5.2. UK
8.5.2.1. Key Country Dynamics
8.5.2.2. Regulatory Framework
8.5.2.3. Competitive Insights
8.5.2.4. UK Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.3. Germany
8.5.3.1. Key Country Dynamics
8.5.3.2. Regulatory Framework
8.5.3.3. Competitive Insights
8.5.3.4. Germany Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.4. France
8.5.4.1. Key Country Dynamics
8.5.4.2. Regulatory Framework
8.5.4.3. Competitive Insights
8.5.4.4. France Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.5. Italy
8.5.5.1. Key Country Dynamics
8.5.5.2. Regulatory Framework
8.5.5.3. Competitive Insights
8.5.5.4. Italy Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.6. Spain
8.5.6.1. Key Country Dynamics
8.5.6.2. Regulatory Framework
8.5.6.3. Competitive Insights
8.5.6.4. Spain Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.7. Norway
8.5.7.1. Key Country Dynamics
8.5.7.2. Regulatory Framework
8.5.7.3. Competitive Insights
8.5.7.4. Norway Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.8. Denmark
8.5.8.1. Key Country Dynamics
8.5.8.2. Regulatory Framework
8.5.8.3. Competitive Insights
8.5.8.4. Denmark Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.9. Sweden
8.5.9.1. Key Country Dynamics
8.5.9.2. Regulatory Framework
8.5.9.3. Competitive Insights
8.5.9.4. Sweden Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
8.6.2. Japan
8.6.2.1. Key Country Dynamics
8.6.2.2. Regulatory Framework
8.6.2.3. Competitive Insights
8.6.2.4. Japan Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.3. China
8.6.3.1. Key Country Dynamics
8.6.3.2. Regulatory Framework
8.6.3.3. Competitive Insights
8.6.3.4. China Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.4. India
8.6.4.1. Key Country Dynamics
8.6.4.2. Regulatory Framework
8.6.4.3. Competitive Insights
8.6.4.4. India Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.5. South Korea
8.6.5.1. Key Country Dynamics
8.6.5.2. Regulatory Framework
8.6.5.3. Competitive Insights
8.6.5.4. South Korea Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.6. Australia
8.6.6.1. Key Country Dynamics
8.6.6.2. Regulatory Framework
8.6.6.3. Competitive Insights
8.6.6.4. Australia Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.7. Thailand
8.6.7.1. Key Country Dynamics
8.6.7.2. Regulatory Framework
8.6.7.3. Competitive Insights
8.6.7.4. Thailand Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7. Latin America
8.7.1. Latin America Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
8.7.2. Brazil
8.7.2.1. Key Country Dynamics
8.7.2.2. Regulatory Framework
8.7.2.3. Competitive Insights
8.7.2.4. Brazil Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7.3. Argentina
8.7.3.1. Key Country Dynamics
8.7.3.2. Regulatory Framework
8.7.3.3. Competitive Insights
8.7.3.4. Argentina Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8. MEA
8.8.1. MEA Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
8.8.2. South Africa
8.8.2.1. Key Country Dynamics
8.8.2.2. Regulatory Framework
8.8.2.3. Competitive Insights
8.8.2.4. South Africa Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key Country Dynamics
8.8.3.2. Regulatory Framework
8.8.3.3. Competitive Insights
8.8.3.4. Saudi Arabia Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.4. UAE
8.8.4.1. Key Country Dynamics
8.8.4.2. Regulatory Framework
8.8.4.3. Competitive Insights
8.8.4.4. UAE Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key Country Dynamics
8.8.5.2. Regulatory Framework
8.8.5.3. Competitive Insights
8.8.5.4. Kuwait Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Participant Overview
9.2. Company Market Position Analysis
9.3. Company Categorization
9.4. Strategy Mapping
9.5. Company Profiles/Listing
9.5.1. GSK plc
9.5.1.1. Overview
9.5.1.2. Financial Performance
9.5.1.3. Product Benchmarking
9.5.1.4. Strategic Initiatives
9.5.2. Teva Pharmaceutical Industries Ltd
9.5.2.1. Overview
9.5.2.2. Financial Performance
9.5.2.3. Product Benchmarking
9.5.2.4. Strategic Initiatives
9.5.3. AptarGroup, Inc.
9.5.3.1. Overview
9.5.3.2. Financial Performance
9.5.3.3. Product Benchmarking
9.5.3.4. Strategic Initiatives
9.5.4. UCB S.A., Belgium
9.5.4.1. Overview
9.5.4.2. Financial Performance
9.5.4.3. Product Benchmarking
9.5.4.4. Strategic Initiatives
9.5.5. Teleflex Incorporated
9.5.5.1. Overview
9.5.5.2. Financial Performance
9.5.5.3. Product Benchmarking
9.5.5.4. Strategic Initiatives
9.5.6. 3M
9.5.6.1. Overview
9.5.6.2. Financial Performance
9.5.6.3. Product Benchmarking
9.5.6.4. Strategic Initiatives
9.5.7. Bespak Limited
9.5.7.1. Overview
9.5.7.2. Financial Performance
9.5.7.3. Product Benchmarking
9.5.7.4. Strategic Initiatives
9.5.8. Optinose
9.5.8.1. Overview
9.5.8.2. Financial Performance
9.5.8.3. Product Benchmarking
9.5.8.4. Strategic Initiatives
9.5.9. Intersect ENT
9.5.9.1. Overview
9.5.9.2. Financial Performance
9.5.9.3. Product Benchmarking
9.5.9.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global intranasal drug and vaccine delivery market, by region, 2018 - 2030 (USD Million)
Table 4 Global intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 5 Global intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 6 Global intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 7 Global intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 8 North America intranasal drug and vaccine delivery market, by country, 2018 - 2030 (USD Million)
Table 9 North America intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 10 North America intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 11 North America intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 12 North America intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 13 U.S intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 14 U.S intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 15 U.S intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 16 U.S intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 17 Canada intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 18 Canada intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 19 Canada intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 20 Canada intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 21 Mexico intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 22 Mexico intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 23 Mexico intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 24 Mexico intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 25 Europe intranasal drug and vaccine delivery market, by country, 2018 - 2030 (USD Million)
Table 26 Europe intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 27 Europe intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 28 Europe intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 29 Europe intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 30 UK intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 31 UK intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 32 UK intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 33 UK intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 34 Germany intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 35 Germany intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 36 Germany intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 37 Germany intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 38 France intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 39 France intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 40 France intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 41 France intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 42 Italy intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 43 Italy intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 44 Italy intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 45 Italy intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 46 Spain intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 47 Spain intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 48 Spain intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 49 Spain intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 50 Denmark intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 51 Denmark intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 52 Denmark intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 53 Denmark intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 54 Sweden intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 55 Sweden intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 56 Sweden intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 57 Sweden intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 58 Norway intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 59 Norway intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 60 Norway intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 61 Norway intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 62 Asia Pacific intranasal drug and vaccine delivery market, by country, 2018 - 2030 (USD Million)
Table 63 Asia Pacific intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 64 Asia Pacific intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 65 Asia Pacific intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 66 Asia Pacific intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 67 China intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 68 China intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 69 China intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 70 China intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 71 Japan intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 72 Japan intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 73 Japan intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 74 Japan intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 75 India intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 76 India intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 77 India intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 78 India intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 79 Australia intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 80 Australia intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 81 Australia intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 82 Australia intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 83 South Korea intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 84 South Korea intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 85 South Korea intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 86 South Korea intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 87 Thailand intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 88 Thailand intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 89 Thailand intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 90 Thailand intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 91 Latin America intranasal drug and vaccine delivery market, by country, 2018 - 2030 (USD Million)
Table 92 Latin America intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 93 Latin America intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 94 Latin America intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 95 Latin America intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 96 Brazil intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 97 Brazil intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 98 Brazil intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 99 Brazil intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 100 Argentina intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 101 Argentina intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 102 Argentina intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 103 Argentina intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa Intranasal drug and vaccine delivery market, by country, 2018 - 2030 (USD Million)
Table 105 Middle East & Africa intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 106 Middle East & Africa intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 107 Middle East & Africa intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 108 Middle East & Africa intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 109 South Africa intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 110 South Africa intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 111 South Africa intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 112 South Africa intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 117 UAE intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 118 UAE intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 119 UAE intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 120 UAE intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 121 Kuwait intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 122 Kuwait intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 123 Kuwait intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 124 Kuwait intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Intranasal drug and vaccine delivery market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Product and dosage outlook (USD Million)
Fig. 10 Application and distribution channel outlook
Fig. 11 Competitive landscape
Fig. 12 Intranasal drug and vaccine delivery market dynamics
Fig. 13 Intranasal drug and vaccine delivery market: Porter’s five forces analysis
Fig. 14 Intranasal drug and vaccine delivery market: PESTLE analysis
Fig. 15 Intranasal drug and vaccine delivery market: Product segment dashboard
Fig. 16 Intranasal drug and vaccine delivery market: Product market share analysis, 2024 & 2030
Fig. 17 Powder delivery device market, 2018 - 2030 (USD Million)
Fig. 18 Liquid delivery device (metered spray pumps) market, 2018 - 2030 (USD Million)
Fig. 19 Pressurized metered dose inhaler market, 2018 - 2030 (USD Million)
Fig. 20 Others market, 2018 - 2030 (USD Million)
Fig. 21 Intranasal drug and vaccine delivery market: Dosage segment dashboard
Fig. 22 Intranasal drug and vaccine delivery market: Dosage market share analysis, 2024 & 2030
Fig. 23 Unit-dose market, 2018 - 2030 (USD Million)
Fig. 24 Multi-dose market, 2018 - 2030 (USD Million)
Fig. 25 Intranasal drug and vaccine delivery market: Application segment dashboard
Fig. 26 Intranasal drug and vaccine delivery market: Application market share analysis, 2024 & 2030
Fig. 27 Respiratory disorders market, 2018 - 2030 (USD Million)
Fig. 28 Neurological disorders market, 2018 - 2030 (USD Million)
Fig. 29 Vaccination market, 2018 - 2030 (USD Million)
Fig. 30 Pain management market, 2018 - 2030 (USD Million)
Fig. 31 Others market, 2018 - 2030 (USD Million)
Fig. 32 Intranasal drug and vaccine delivery market: Distribution channel segment dashboard
Fig. 33 Intranasal drug and vaccine delivery market: Distribution channel market share analysis, 2024 & 2030
Fig. 34 Hospital pharmacies market, 2018 - 2030 (USD Million)
Fig. 35 Retail pharmacies market, 2018 - 2030 (USD Million)
Fig. 36 Online pharmacies market, 2018 - 2030 (USD Million)
Fig. 37 Intranasal drug and vaccine delivery market revenue, by region
Fig. 38 Regional marketplace: Key takeaways
Fig. 39 Regional marketplace: Key takeaways
Fig. 40 North America intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 41 U.S. country dynamics
Fig. 42 U.S. intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 43 Canada country dynamics
Fig. 44 Canada intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 45 Mexico country dynamics
Fig. 46 Mexico intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 47 Europe intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 48 UK country dynamics
Fig. 49 UK intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 50 Germany country dynamics
Fig. 51 Germany intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 52 France country dynamics
Fig. 53 France intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 54 Italy country dynamics
Fig. 55 Italy intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 56 Spain country dynamics
Fig. 57 Spain intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 58 Norway country dynamics
Fig. 59 Norway intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 60 Sweden country dynamics
Fig. 61 Sweden intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 62 Denmark country dynamics
Fig. 63 Denmark intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 64 Asia Pacific intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 65 Japan country dynamics
Fig. 66 Japan intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 67 China country dynamics
Fig. 68 China intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 69 India country dynamics
Fig. 70 India intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 71 Australia country dynamics
Fig. 72 Australia intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 73 South Korea country dynamics
Fig. 74 South Korea intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 75 Thailand country dynamics
Fig. 76 Thailand intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 77 Latin America intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 78 Brazil country dynamics
Fig. 79 Brazil intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 80 Argentina country dynamics
Fig. 81 Argentina intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 82 MEA intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 83 South Africa country dynamics
Fig. 84 South Africa intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 85 Saudi Arabia country dynamics
Fig. 86 Saudi Arabia intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 87 UAE country dynamics
Fig. 88 UAE intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 89 Kuwait country dynamics
Fig. 90 Kuwait intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 91 Company categorization
Fig. 92 Company market position analysis
Fig. 93 Strategic framework

Companies Mentioned

  • GSK plc
  • Teva Pharmaceutical Industries Ltd
  • AptarGroup, Inc.
  • UCB S.A., Belgium
  • Teleflex Incorporated
  • 3M
  • Bespak Limited
  • Optinose
  • Intersect ENT

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages100
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 70.32 Billion
Forecasted Market Value ( USD ) by 2030 $ 103.33 Billion
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Intranasal Drug & Vaccine Delivery Market by Product, Dosage, Application, Distribution Channel - Global Forecast 2025-2030 - Product Image

Intranasal Drug & Vaccine Delivery Market by Product, Dosage, Application, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Vaccine Delivery Devices - Global Strategic Business Report - Product Image

Vaccine Delivery Devices - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Vaccine Delivery Devices Market by Nature, Product Type - Global Forecast 2025-2030 - Product Image

Vaccine Delivery Devices Market by Nature, Product Type - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Vaccine Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Vaccine Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 120 Pages
  • Global
From
Vaccine Delivery Devices Global Market Report 2024 - Product Image

Vaccine Delivery Devices Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.